Join us at #CERTAINTY Europe on Oct 29! Dr. Ioannis Loisios-Konstantinidis of Novartis will reveal how PBPK modeling replaced 10+ clinical studies in Scemblix’s NDA, shaping regulatory review and drug labeling. See the full agenda and register: https://lnkd.in/eq9XeUXY #CertaintybyCertara #DrugDevelopment #MIDD
About us
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
- Website
-
https://www.certara.com
External link for Certara
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Radnor, Pennsylvania
- Type
- Public Company
- Specialties
- model-based drug discovery and development, scientific informatics, PK/PD modeling and simulation, PBPK modeling and simulation, trial design, drug development, regulatory writing, quantitative systems pharmacology, clinical pharmacology, quantitative systems toxicology, transparency and disclosure, model-based meta-analysis, regulatory strategy, regulatory publishing, market access, health economics and outcomes research, and real world evidence solutions
Locations
Employees at Certara
Updates
-
Are you attending AAPS in Salt Lake and curious about how AI is revolutionizing drug discovery and development? Don’t miss Piet Van Der Graaf’s closing plenary lecture at #PharmSci360! Piet will present real-world case studies that showcase how AI and machine learning are transforming the field. Discover how we can link chemometrics to PBPK, QSP models, and clinical databases to predict clinical endpoints using virtual patients and biomarkers. Tap below to hear from Piet! We can’t wait to connect with you at this talk and at booth #2310. See you there!
-
Thank you to Greg Licholai for highlighting the impact and value of AI Simulations that help Drug Trials. Check out his contributed insights in this Forbes’ latest article which shines a light on our feature in Pharma Focus Europe. https://ow.ly/ioyM50TJOFm Greg shares how Certara’s AI-powered simulations are speeding up clinical trials, fine-tuning dosing, and increasing the success rates of new drugs entering human studies. In the Pharma Focus article, Certara experts, Amin Rostami-Hodjegan and Piet Van Der Graaf, explain how combining AI with advanced modeling is helping pharmaceutical companies predict trial outcomes with greater precision. This means safer, more efficient, and cost-effective drug development. We are just getting started with AI powered biosimulation and there is so much potential to transform the drug discovery and development process for good for all! #CertaraAI #DrugDevelopment #ClinicalTrials #PharmaInnovation #Forbes
-
In part three of her video interview series with Applied Clinical Trials Magazine, Erin Erginer, Director of Product at Certara, touches on the burden put on stakeholders to ensure proper data collection. Watch the full interview here: https://ow.ly/UECZ50TEf8H #Pinnacle21 #DataManagement #ClinicalTrials
Ensuring Proper Data Collection
appliedclinicaltrialsonline.com
-
Getting ready for #AMWA2024 in New Orleans: Certara is excited to bring you a great lineup of presentations, roundtables, and discussions led by our experts. Swipe to check out the Certara-hosted events and mark your calendars! More details coming soon. Don’t miss the chance to connect with us at AMWA 2024 in the Big Easy: https://ow.ly/Z7EL50TJKxx #MedicalWriting
-
The October 2024 edition of Certara’s Simcyp Library Bulletin is here, packed with groundbreaking research and applications in pharmacokinetics and drug development. https://lnkd.in/epNT35Nx Highlights include: 🔬 Innovative Research: Dive into studies on drug distribution in lactation, antiparkinsonian drug exposure in the elderly, and more. 📊 Advanced PBPK Modeling: Explore applications in drug-drug interaction potential, dosing decisions for geriatric patients, and understanding food effects on drug absorption. 📖 Educational Resources: Access tutorials and comprehensive analyses to enhance your knowledge and application of PBPK approaches. Check out the recently published research here: https://lnkd.in/epNT35Nx #Pharmacokinetics #DrugDevelopment #PBPK #Simcyp #Certara #ClinicalTrials
-
Just a few weeks away! Join us for #Certainty by Certara in Mainz, Germany, on October 29-30, 2024! Check out our video reel for a sneak peek at the insights and connections waiting for you. Engage with industry leaders and explore the latest in drug development and biosimulation. Explore our lineup and register here: https://lnkd.in/eq9XeUXY
-
In a recent video interview, Erin Erginer, Director of Product at Certara spoke to Applied Clinical Trials Magazine about the growing volume and complexity of data in clinical trials, and how this is impacting the industry in terms of end of study timelines and increased costs. Watch now: https://ow.ly/SFM850TIHmV? #DataManagement #ClinicalTrials #Pinnacle21 #Certara
Consequences of Improper Data Collection
appliedclinicaltrialsonline.com
-
Join us in Mainz, Germany on October 29-30 for an exclusive client event featuring a must-attend panel on "Speeding Time to Insights with Digital Data Flow, Automation, and Analytics." Explore the cutting edge of data flow and automation with industry leaders Esther Vock, PhD, Matthieu Chaton, Wolfgang Prange, PhD, and moderator, Bryan Farrow. For the full agenda and to register, visit: https://lnkd.in/eq9XeUXY #CertaraCertainty #CertaintyEurope #CERTAINTY2024 #drugdevelopment
-
Attending AAPS #PharmSci360? Join us for an exciting Lunch and Learn with Certara's top experts in Quantitative Systems Pharmacology (QSP) modeling, Piet Van Der Graaf and Fei Hua. They will discuss how QSP integrates in vitro data, in vivo PK and PD data, drug mechanisms, and disease biology to revolutionize drug discovery and development. Schedule time to connect with our consultants and view our full lineup: https://lnkd.in/eMXzA4ZQ